FitLife Brands (FTLF) Competitors $19.11 +0.34 (+1.81%) Closing price 10/23/2025 04:00 PM EasternExtended Trading$20.00 +0.89 (+4.65%) As of 10/23/2025 07:13 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock FTLF vs. ERAS, GHRS, REPL, RGNX, ARCT, CMPS, KROS, ZVRA, CTMX, and SIGAShould you be buying FitLife Brands stock or one of its competitors? The main competitors of FitLife Brands include Erasca (ERAS), GH Research (GHRS), Replimune Group (REPL), REGENXBIO (RGNX), Arcturus Therapeutics (ARCT), COMPASS Pathways (CMPS), Keros Therapeutics (KROS), Zevra Therapeutics (ZVRA), CytomX Therapeutics (CTMX), and Siga Technologies (SIGA). These companies are all part of the "pharmaceutical products" industry. FitLife Brands vs. Its Competitors Erasca GH Research Replimune Group REGENXBIO Arcturus Therapeutics COMPASS Pathways Keros Therapeutics Zevra Therapeutics CytomX Therapeutics Siga Technologies FitLife Brands (NASDAQ:FTLF) and Erasca (NASDAQ:ERAS) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, risk, valuation, analyst recommendations, dividends, earnings and profitability. Is FTLF or ERAS more profitable? FitLife Brands has a net margin of 12.63% compared to Erasca's net margin of 0.00%. FitLife Brands' return on equity of 21.70% beat Erasca's return on equity.Company Net Margins Return on Equity Return on Assets FitLife Brands12.63% 21.70% 13.45% Erasca N/A -31.19%-26.34% Do analysts rate FTLF or ERAS? FitLife Brands currently has a consensus price target of $23.00, indicating a potential upside of 20.36%. Erasca has a consensus price target of $3.75, indicating a potential upside of 69.68%. Given Erasca's higher probable upside, analysts clearly believe Erasca is more favorable than FitLife Brands.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score FitLife Brands 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.00Erasca 2 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.44 Which has preferable earnings & valuation, FTLF or ERAS? FitLife Brands has higher revenue and earnings than Erasca. Erasca is trading at a lower price-to-earnings ratio than FitLife Brands, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFitLife Brands$64.47M2.78$8.98M$0.8422.75ErascaN/AN/A-$161.65M-$0.45-4.91 Which has more risk & volatility, FTLF or ERAS? FitLife Brands has a beta of 0.65, indicating that its share price is 35% less volatile than the S&P 500. Comparatively, Erasca has a beta of 1.18, indicating that its share price is 18% more volatile than the S&P 500. Does the media favor FTLF or ERAS? In the previous week, Erasca had 1 more articles in the media than FitLife Brands. MarketBeat recorded 1 mentions for Erasca and 0 mentions for FitLife Brands. Erasca's average media sentiment score of 0.34 beat FitLife Brands' score of 0.00 indicating that Erasca is being referred to more favorably in the news media. Company Overall Sentiment FitLife Brands Neutral Erasca Neutral Do insiders & institutionals have more ownership in FTLF or ERAS? 2.3% of FitLife Brands shares are held by institutional investors. Comparatively, 67.8% of Erasca shares are held by institutional investors. 61.4% of FitLife Brands shares are held by company insiders. Comparatively, 14.4% of Erasca shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. SummaryFitLife Brands beats Erasca on 10 of the 16 factors compared between the two stocks. Get FitLife Brands News Delivered to You Automatically Sign up to receive the latest news and ratings for FTLF and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding FTLF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FTLF vs. The Competition Export to ExcelMetricFitLife BrandsMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$176.27M$10.98B$6.17B$10.57BDividend YieldN/A1.87%5.72%4.83%P/E Ratio22.7520.8729.6528.46Price / Sales2.7831.63492.47188.31Price / Cash18.5324.6936.5560.64Price / Book4.863.4812.026.53Net Income$8.98M$210.63M$3.32B$276.75M7 Day Performance7.97%0.10%0.60%0.93%1 Month Performance0.31%-0.14%5.14%1.41%1 Year Performance18.59%-7.77%61.13%31.59% FitLife Brands Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FTLFFitLife Brands3.3851 of 5 stars$19.11+1.8%$23.00+20.4%+17.4%$176.27M$64.47M22.7520ERASErasca2.8988 of 5 stars$2.40-2.6%$3.75+56.6%-14.3%$679.39MN/A-5.32120GHRSGH Research2.4791 of 5 stars$12.97-7.4%$30.38+134.3%+76.7%$675.87MN/A-17.5510Positive NewsREPLReplimune Group4.4395 of 5 stars$8.43-5.7%$11.00+30.5%-29.9%$658.05MN/A-2.60210Trending NewsAnalyst RevisionRGNXREGENXBIO4.3846 of 5 stars$13.01+2.9%$28.38+118.1%+29.2%$656.38M$83.33M-3.78370ARCTArcturus Therapeutics3.4479 of 5 stars$23.45+9.0%$50.57+115.6%-40.0%$638.33M$109.80M-10.54180Trending NewsAnalyst DowngradeHigh Trading VolumeCMPSCOMPASS Pathways2.8346 of 5 stars$6.55-3.0%$16.00+144.5%-3.1%$626.97MN/A-3.55120Upcoming EarningsKROSKeros Therapeutics3.2869 of 5 stars$15.37+1.2%$30.00+95.2%-74.3%$623.92M$3.55M49.55100ZVRAZevra Therapeutics2.7228 of 5 stars$10.98-1.6%$24.00+118.7%+33.3%$615.47M$23.61M-52.2120Gap UpCTMXCytomX Therapeutics4.3331 of 5 stars$3.68-1.7%$5.83+58.7%+205.6%$606.04M$138.10M6.56170Analyst ForecastSIGASiga Technologies2.0014 of 5 stars$8.42-0.8%N/A+27.1%$602.96M$138.72M7.4540 Related Companies and Tools Related Companies Erasca Competitors GH Research Competitors Replimune Group Competitors REGENXBIO Competitors Arcturus Therapeutics Competitors COMPASS Pathways Competitors Keros Therapeutics Competitors Zevra Therapeutics Competitors CytomX Therapeutics Competitors Siga Technologies Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FTLF) was last updated on 10/24/2025 by MarketBeat.com Staff From Our PartnersWhat a Former CIA Agent Knows About the Coming Collapse This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredRefund From 1933: Trump’s Reset May Create Instant WealthFed vs. Trump - A War With American Wealth At Stake The Fed's defiance of Trump thickens the plot to contro...American Hartford Gold | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredIt’s Time to Buy “the NVIDIA of Quantum Computing”Yahoo Finance wrote that investing in quantum computing could... "Lead to life-changing returns... and make...Brownstone Research | SponsoredApple's secret partnerThe Tiny Company Apple Can’t Live Without A tiny company holds the key to Apple’s biggest breakthrough sinc...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding FitLife Brands Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share FitLife Brands With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.